Table 4 The relation between the BCR::ABL1 and ABL amplification and other clinical features and haematological parameters
BCR::ABL1 and ABL amplification | Test value | P value | ||||
|---|---|---|---|---|---|---|
Negative | ABL | BCR::ABL 1 | ||||
No. = 42 | No. = 4 | No. = 3 | ||||
Age | Mean ± SD | 47.2 ± 15.2 | 39.5 ± 16.0 | 51.6 ± 5.5 | 0.645• | 0.529 |
Range | 20–75 | 20–58 | 46–57 | |||
Sex | Female | 24 (57.1%) | 1 (25.0%) | 1 (33.3%) | 2.014* | 0.365 |
Male | 18 (42.9%) | 3 (75.0%) | 2 (66.7%) | |||
Spleen | Moderate | 16 (38.1%) | 1 (25.0%) | 1 (33.3%) | 0.285* | 0.867 |
Huge | 26 (61.9%) | 3 (75.0%) | 2 (66.7%) | |||
TLC | Median (IQR) | 101.5 (54–199) | 64 (35–149) | 57 (41–109) | 2.252 ≠ | 0.324 |
Range | 32–283 | 29–211 | 41–109 | |||
Hb | Mean ± SD | 8.7 ± 1.3 | 9.0 ± 1.3 | 7.2 ± 0.5 | 1.885• | 0.163 |
Range | 6.3–11.1 | 8–11 | 6.9–7.9 | |||
Plat | Median (IQR) | 410.5 (93–545) | 310 (84–547) | 54 (34–82) | 5.502 ≠ | 0.064 |
Range | 45–900 | 78–564 | 34–82 | |||
PB blast | Median (IQR) | 4 (3–9) | 7.5 (3.5–15.5) | 23 (12–25) | 6.983 ≠ | 0.030 |
Range | 1–36 | 3–20 | 12–25 | |||
BM blasts | Median (IQR) | 8 (6–15) | 10 (6.5–22) | 35 (18–61) | 4.861 ≠ | 0.088 |
Range | 5–53 | 6–31 | 18–61 | |||